下载掌阅APP，畅读海量书库
立即打开
[1]Born GV. Evidence for the formation of a labile phospholipoprotein during the clotting of platelet-rich plasma.Nature，1957，180（4585）：546-547.
[2]Marx RE. Platelet-rich plasma（PRP）：what is PRP and what is not PRP？ Implant Dent，2001，10（4）：225-228.
[3]Ross R，Glomset J，Kariya B，et al. A Platelet-Dependent Serum Factor that Stimulates the Proliferation of Arterial Smooth Muscle Cells in Vitro. Proc Natl Acad Sci U S A，1974，71（4）：1207-1210.
[4]Witte LD，Kaplan KL，Nossel HL，et al.Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells. Circ Res，1978，42（3）：402-409.
[5]Assoian RK，Grotendorst GR，Miller DM，et al. Cellular transformation by coordinated action of three peptide growth factors from human platelet. Nature，1984，309（5971）：804-806.
[6]Karey KP，Marquardt H，Sirbasku DA. Human platelet-derived mitogens. I. Identification of insulinlike growth factors I and II by purification and N alpha amino acid sequence analysis. Blood，1989，74（3）：1084-1092.
[7]Brunner G，Nguyen H，Gabrilove J，et al. Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood，1993，81（3）：631-638.
[8]Möhle R，Green D，Moore MA，et al. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA，1997，94（2）：663-668.
[9]Matras，H. Die Wirkungen vershiedener Fibrinprapar ate auf Kontinuitat-strennungen der Rattenhaut. Osterr Z Stomatol，1970，67（9）：338-359.
[10]Dohan DM，Choukroun J，Diss A，et al. Platelet-rich fibrin（PRF）：A second-generation platelet concentrate.Part I：Technological concepts and evolution. J Oral Surg Oral Med Oral Pathol Oral Radiol Endod，2006，101（3）：e37-e44.
[11]Hood AG，Hill AG，Reeder CD. Perioperative autologous sequestratio n Ⅲ：a new physilolgic glue with wound healing properties. Proc Am Cardiovasc Perfusion，1993，14：126-129.
[12]Whitman DH，Berry RL，Green DM. Platelet gel：an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg，1997，55（11）：1294-1299.
[13]Choukroun J，Adda F，Schoeffler C，et al.Une opportunite en paro-implantologie：le PRF. Implantodontie，2001，42：55-62.
[14]Dohan Ehrenfest DM，Rasmusson L，Albrektsson T. Classification of platelet concentrates：from pure plateletrich plasma（P-PRP）to leucocyte-and platelet-rich fibrin（L-PRF）. Trends Biotechnol，2009，27（3）：158-167.
[15]Sclafani AP. Safety，efficacy，and utility of platelet-rich fibrin matrix in facial plastic surgery. Arch Facial Plast Surg，2011，13（4）：247-251.
[16]Dohan Ehrenfest DM，Bielecki T，Del Corso M，et al. Shedding light in the controversial terminology for platelet-rich products：platelet-rich plasma（PRP），platelet-rich fibrin（PRF），platelet-leukocyte gel（PLG），preparation rich in growth factors（PRGF），classification and commercialism. J Biomed Mater Res A，2010，95（4）：1280-1282.
[17]张长青，袁霆.富血小板血浆在临床应用中的争议与研究进展. 中华关节外科杂志（电子版），2016，10（6）：588-591.
[18]程飚. 浓缩血小板产品在创伤外科应用中的问题与思考. 创伤外科杂志，2018，20（11）：7-11.
[19]DeLong JM，Russell RP，Mazzocca AD.Platelet-rich plasma：the PAW classification system.Arthroscopy，2012，28（7）：998-1009.
[20]Mautner K，Malanga GA，Smith J，et al.A call for a standard classification system for future biologic research：the rationale for new PRP nomenclature.PM R，2015，7（4 Suppl）：S53-S59.
[21]Magalon J，Chateau AL，Bertrand B，et al.DEPA classification：a proposal for standardising PRP use and a retrospective application of available devices.BMJ Open Sport Exerc Med，2016，2（1）：e000060.
[22]Lana J，Purita J，Paulus C，et al.Contributions for classification of platelet rich plasma-proposal of a new classification：MARSPILL. Regen Med，2017，12（5）：565-574.
[23]Paul H.The use of platelets in regenerative medicine and proposal for a new classification system：guidance from the SSC of the ISTH.J Thromb Haemost，2018，16（9）：1895-1900.
[24]Acebes-Huerta A，Arias-Fernandez T，Bernardo A，et al.Platelet-derived bio-products：classification update，applications，concerns and new perspectives.Transfus Apher Sci，2019，59（1）：102716.